Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $17.3M in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Quince Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −20 vs. Q1 2026
- Shares held
- 330.1K
- −13.9M (−97.7%) vs. Q1 2026
- Total value
- $17.3M
- +$15.9M (+1,099.3%) vs. Q1 2026
- New holders
- 10
- 3 more added
- Sold out
- 30
- 13 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $17.3M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $20.0M |
| Q2 2025 | 41 | $12.8M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.73M |
| Q4 2023 | 44 | $7.84M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $249.2M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Balyasny Asset Management LLC | 69,967 | $12.6M | 0.02% | +69,967 | New |
| Ikarian Capital, LLC | 72,251 | $1.31M | 0.22% | +72,251 | New |
| Millennium Management LLC | 70,779 | $1.29M | 0.00% | −2,432,938−97.2% | Reduced |
| Squadron Capital Management LLC | 40,375 | $734.4K | 0.25% | +40,375 | New |
| Shay Capital LLC | 17,468 | $329.3K | 0.04% | −1,755,441−99.0% | Reduced |
| Boothbay Fund Management, LLC | 13,911 | $253.0K | 0.00% | +13,911 | New |
| Jane Street Group, LLC | 12,642 | $230.0K | 0.00% | +12,642 | New |
| Vanguard Capital Management LLC | 12,044 | $219.1K | 0.00% | −449,433−97.4% | Reduced |
| Cormorant Asset Management, LP | 5,498 | $100.0K | 0.01% | +5,498 | New |
| UBS Group AG | 4,730 | $86.0K | 0.00% | +4,174+750.7% | Added |
| Morgan Stanley | 4,084 | $74.3K | 0.00% | +3,250+389.7% | Added |
| Vanguard Fiduciary Trust Co | 3,614 | $65.7K | 0.00% | −228,712−98.4% | Reduced |
| BlackRock, Inc. | 1,702 | $31.0K | 0.00% | −471,557−99.6% | Reduced |
| Tower Research Capital LLC (TRC) | 567 | $10.3K | 0.00% | −8,173−93.5% | Reduced |
| Gen-Wealth Partners Inc | 165 | $3.00K | 0.00% | −32,853−99.5% | Reduced |
| Operose Advisors LLC | 159 | $2.89K | 0.00% | +159 | New |
| Fortitude Family Office, LLC | 40 | $728 | 0.00% | −8,055−99.5% | Reduced |
| Barclays PLC | 27 | $491 | 0.00% | +23+575.0% | Added |
| Wells Fargo & Company | 10 | $182 | 0.00% | +10 | New |
| Allworth Financial LP | 8 | $137 | 0.00% | +8 | New |
| Parallel Advisors, LLC | 3 | $55 | 0.00% | −792−99.6% | Reduced |
| JDM Financial Group LLC | 1 | $18 | 0.00% | −339−99.7% | Reduced |
| Westside Investment Management, Inc. | 1 | $18 | 0.00% | −74−98.7% | Reduced |
| Steward Partners Investment Advisory, LLC | 1 | $18 | 0.00% | +1 | New |
| JPMorgan Chase & Co | 2 | $2 | 0.00% | −467−99.6% | Reduced |
| Royal Bank of Canada | 1 | $0 | 0.00% | −3,290−100.0% | Reduced |
| Woodline Partners LP | 0 | $0 | 0.00% | −5,200,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −1,750,862−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −600,105−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −248,011−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −172,640−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −154,093−100.0% | Sold out |
| JustInvest LLC | 0 | $0 | 0.00% | −132,661−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −71,223−100.0% | Sold out |
| Northern Trust Corp | 0 | $0 | 0.00% | −65,931−100.0% | Sold out |
| Intellectus Partners, LLC | 0 | $0 | 0.00% | −53,312−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −50,100−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −48,812−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Nordwand Advisors, LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −15,200−100.0% | Sold out |
| Scharf Investments, LLC | 0 | $0 | 0.00% | −19,461−100.0% | Sold out |
| Vanguard Global Advisers, LLC | 0 | $0 | 0.00% | −19,514−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −16,064−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −13,080−100.0% | Sold out |
| Alpha Zero LLC | 0 | $0 | 0.00% | −13,000−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −12,673−100.0% | Sold out |
| Nixon Peabody Trust Co | 0 | $0 | 0.00% | −11,126−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,933−100.0% | Sold out |
| Coyle Financial Counsel LLC | 0 | $0 | 0.00% | −10,509−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −5,500−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −550−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Jones Financial Companies LLLP | 0 | $0 | 0.00% | −133−100.0% | Sold out |
| Hurley Capital, LLC | 0 | $0 | 0.00% | −121−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −8−100.0% | Sold out |